Drug Profile
Povidone iodine topical - Veloce BioPharma
Alternative Names: VBP-245Latest Information Update: 25 Jul 2022
Price :
$50
*
At a glance
- Originator Veloce BioPharma
- Class Anti-infectives; Antifungals; Antiseptics; Antivirals; Disinfectants; Eye disorder therapies; Oxidants; Pyrrolidinones; Skin disorder therapies
- Mechanism of Action HN protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Molluscum contagiosum; Warts
Most Recent Events
- 25 Jul 2022 Povidone iodine topical is still in phase-II trials for Warts (In adults, In adolescents, In the elderly, In children) in USA (Topical, Gel) (NCT04253912)
- 12 Feb 2020 Phase-II clinical trials in Warts (In adults, In adolescents, In the elderly, In children) in USA (Topical, Gel) (NCT04253912)
- 05 Feb 2020 Veloce Biopharma plans a phase II trial for Warts (Topical) (NCT04253912)